Literature DB >> 3209530

The pharmacokinetics of norfloxacin in the aged.

A P MacGowan1, M A Greig, E A Clarke, L O White, D S Reeves.   

Abstract

Eight patients aged over 65 years (mean age 81 years), with microbiologically proven urinary tract infections were treated with 400 mg norfloxacin bd daily for six days. Blood samples were taken on day 1 and day 6 to give a concentration-time profile, and on each of the other days samples were obtained before the first dose of the day. Urine was collected throughout. The mean of the maximum serum concentration of norfloxacin after the first dose was 1.5 mg/l (range 1.1-1.8 mg/l) at a mean of 3.2 h (range 1-6 h). After the last dose the mean maximum concentration was 2.2 mg/l (range 1.6-3.7 h) at 3 h (range 1-4 h). The mean serum half life was 5 h (range 3.7-6.5 h) on day 1 and 5.3 h range (4.4-6.2 h) on day 6. Serum pre-dose norfloxacin levels showed no evidence of accumulation. Mean urinary concentrations varied between 95 and 288 mg/l from day 1 to day 6. No significant adverse reactions were noted. No alteration of norfloxacin dose is suggested in the aged with normal renal function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3209530     DOI: 10.1093/jac/22.5.721

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  Ocular penetration of topical ciprofloxacin and norfloxacin drops and their effect upon eyelid flora.

Authors:  J P Leeming; J P Diamond; R Trigg; L White; H B Hoh; D L Easty
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

Review 2.  Quinolone disposition in the elderly. Practical implications.

Authors:  I Nilsson-Ehle; B Ljungberg
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

Review 3.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.